Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/21/1993 | US5246932 Adenosine antagonist such as vasodilation |
09/21/1993 | US5246930 9-substituted compounds of 3α, 11α-epoxy-3,4,5,5aα,6,7,8,8a,9,11,11a-undecahydro-3β,6.alpha.,9-trimethylfurano[3,4-j][1,2]benzodioxepin, processes for their preparation and their use as antiprotozoal and antiviral agents |
09/21/1993 | US5246929 Prophylaxis or treatment of ischemic encephalopathia |
09/21/1993 | US5246926 Cephalosporin derivatives |
09/21/1993 | US5246924 Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil |
09/21/1993 | US5246922 Inotropic agents |
09/21/1993 | US5246726 Iron-containing composition and method for treatment of cancer |
09/21/1993 | US5246711 Dosage form for treating dysthymia |
09/21/1993 | US5246710 Dosage form for treating cyclothymia |
09/21/1993 | US5246709 Antiemetic therapy |
09/21/1993 | US5246706 Laminated elastomer patch |
09/21/1993 | US5246704 Vaginal suppository |
09/21/1993 | US5246702 Process for the purification of commercial carrageenins |
09/21/1993 | US5246697 Kanamycin A with vehicle or support |
09/21/1993 | US5245896 Quick-change tool holder with center height adjustment mechanism |
09/21/1993 | CA2091942A1 Pharmaceutical composition |
09/21/1993 | CA2081280A1 Use of preparations containing chromium and vitamins e and c for controlling carbohydrate and lipid metabolism |
09/21/1993 | CA1322374C Substituted di-t-butylphenols |
09/21/1993 | CA1322372C Tetrahydrobenzothiazoles, and the preparation and use thereof |
09/21/1993 | CA1322371C Carbapenem compound in crystalline form, and its production and use |
09/21/1993 | CA1322370C Phosphate ester derivatives, their preparation and their therapeutic use |
09/21/1993 | CA1322369C 2-(4-sulfur containing-benzylamino)-benzothiazole compounds |
09/21/1993 | CA1322368C Fused heteroalkylene quinolinamines, a process and intermediates for their preparation and their use as medicaments |
09/21/1993 | CA1322367C Thienotriazolodiazepine compounds and pharmaceutical uses thereof |
09/21/1993 | CA1322334C2 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazino- quinoline-3-carboxylic acid- containing compositions and uses thereof |
09/21/1993 | CA1322328C Stabilized compositions containing epidermal growth factor |
09/19/1993 | WO1993018764A2 VERAPAMIL HCl FORMULATION AND OTHER OPHTHALMIC SOLUTIONS WITH BUFFER SYSTEM FOR OCULAR ADMINISTRATION |
09/19/1993 | WO1993018763A1 Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals |
09/19/1993 | CA2102110A1 Verapamil hci formulation and other ophthalmic solutions with buffer system for ocular administration |
09/19/1993 | CA2091874A1 Triazolopyridazine compounds, their production and use |
09/19/1993 | CA2091866A1 Agent for treatment of chronic fatigue syndrome |
09/19/1993 | CA2091829A1 Cyclic aminomethylene bisphosphonate derivatives |
09/19/1993 | CA2091828A1 Risk determination for drug treatment |
09/19/1993 | CA2091715A1 Argatroban preparations for ophthalmic use |
09/19/1993 | CA2091634A1 Enantiomer (-)-n-(2-ethoxyphenyl)-n'- (1,2,2-trimethylpropyl)-2-nitroethene-1-, 1-diamine, process for the preparation thereof and the use thereof |
09/19/1993 | CA2091214A1 Pyrimidine derivatives |
09/18/1993 | CA2091713A1 Dosage aerosols containing the active substance flezelastin and related structures |
09/17/1993 | EP0609210A4 OPTICALLY ACTIVE 5H-PYRROLO 3,4-b]PYRAZINE DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME. |
09/17/1993 | EP0572635A4 Novel compounds having a guanidine structure and pharmaceutical composition containing same. |
09/17/1993 | EP0571593A4 New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them. |
09/17/1993 | CA2092671A1 2-oxoquinoline derivatives |
09/17/1993 | CA2091550A1 New derivatives of physostigmine, their use and pharmaceutical formulations containing them |
09/16/1993 | WO1993018173A2 Cd4 binding agents and inhibitors of collagenase and protein kinase c |
09/16/1993 | WO1993018172A1 Compounds for modulating growth of infectious agents |
09/16/1993 | WO1993018143A1 Dna encoding taurine and gaba transporters and uses thereof |
09/16/1993 | WO1993018057A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation |
09/16/1993 | WO1993018056A1 Isosteric antiherpes peptide derivatives |
09/16/1993 | WO1993018053A1 METHOD FOR MAKING 3α-HYDROXY,3β-SUBSTITUTED-PREGNANES |
09/16/1993 | WO1993018050A1 Sugar derivatives of macrolides |
09/16/1993 | WO1993018049A1 Fluorosugar derivatives of macrolides |
09/16/1993 | WO1993018048A1 2-aminosugar derivatives of macrolides |
09/16/1993 | WO1993018044A1 Cephalosporin derivatives |
09/16/1993 | WO1993018042A1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
09/16/1993 | WO1993018040A1 Cyclic ketal derivatives |
09/16/1993 | WO1993018039A1 Cyclic ketal derivatives |
09/16/1993 | WO1993018037A1 Epibatidine and derivatives, compositions and methods of treating pain |
09/16/1993 | WO1993018036A1 Condensed indole derivatives as 5ht4-receptor antagonists |
09/16/1993 | WO1993018034A1 Process for the preparation of ergoline derivatives |
09/16/1993 | WO1993018033A1 Biologically active tropane derivatives |
09/16/1993 | WO1993018032A1 Indole derivatives as 5-ht1 agonists |
09/16/1993 | WO1993018030A1 Benzimidazole derivatives as angiotensin ii antagonists |
09/16/1993 | WO1993018029A1 Imidazole, triazole and tetrazole derivatives |
09/16/1993 | WO1993018028A1 Indole derivatives as 5ht1c antagonists |
09/16/1993 | WO1993018027A1 Nitrogen containing heterocyclic compounds useful as pharmaceuticals |
09/16/1993 | WO1993018025A1 N,n'-disubstituted amide derivative |
09/16/1993 | WO1993018024A1 1-alkoxy-2-(alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
09/16/1993 | WO1993018023A1 Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
09/16/1993 | WO1993018009A1 Antiviral nucleoside analogues |
09/16/1993 | WO1993018006A1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
09/16/1993 | WO1993018003A1 Substitued pipecolinic acid derivatives as hiv protease inhibitors |
09/16/1993 | WO1993018002A1 Quaternary salts of 4-substituted piperidines, preparation thereof and pharmaceutical compositions containing same |
09/16/1993 | WO1993017991A1 TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS |
09/16/1993 | WO1993017746A1 Antibacterial coated medical implants |
09/16/1993 | WO1993017717A1 Compositions and methods for modulating rna |
09/16/1993 | WO1993017713A1 Pharmaceutical composition having site-specific delivery |
09/16/1993 | WO1993017711A1 New cyclodextrins and new formulated drugs |
09/16/1993 | WO1993017709A1 Antipruritic |
09/16/1993 | WO1993017696A1 Method for kidney tubulogenesis |
09/16/1993 | WO1993017695A1 Diagnosis and treatment of various neuralgias |
09/16/1993 | WO1993017692A1 Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof |
09/16/1993 | WO1993017691A2 Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease |
09/16/1993 | WO1993017690A1 Halichondrins and related compounds |
09/16/1993 | WO1993017689A1 Method for protection against genotoxic mutagenesis |
09/16/1993 | WO1993017687A1 Topical compositions containing steroids |
09/16/1993 | WO1993017686A1 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses |
09/16/1993 | WO1993017685A1 Combinations of ace inhibitors and diuretics |
09/16/1993 | WO1993017684A2 Enantiomeric hydroxylated xanthine compounds |
09/16/1993 | WO1993017683A1 Application of 2-amino 6-trifluoromethoxy benzothiazole (riluzole) for obtaining a drug useful in the treatment of motor neuron diseases |
09/16/1993 | WO1993017682A1 Angiotensin ii receptor antagonists |
09/16/1993 | WO1993017680A1 Antipyretic and analgesic methods and compositions containing optically pure r-etodolac |
09/16/1993 | WO1993017679A1 Compositions containing ranitidine/bismuth carboxylates salts |
09/16/1993 | WO1993017677A1 Antipyretic and analgesic methods and compositions containing optically pure r(-) ketoprofen |
09/16/1993 | WO1993017676A1 Antifungal agents |
09/16/1993 | WO1993017675A1 Use of alkylureas and hydroxyurea as contraceptive agents |
09/16/1993 | WO1993017674A1 Topical use of local anaesthetic agents for rheumatoid arthritis as well as a pharmaceutical preparation and a method for the treatment thereof |
09/16/1993 | WO1993017673A1 Sustained release analgesics |
09/16/1993 | WO1993017672A1 Treatment of migraine |
09/16/1993 | WO1993017671A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
09/16/1993 | WO1993017670A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
09/16/1993 | WO1993017667A1 Composition for oral preparations |